Atlas Trials

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Clinical trial NCT05440383 · COMPLETED

Trial details

NCT number
NCT05440383
Sponsor
Kissei Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Uterine Fibroids (MeSH Heading: Leiomyoma)
Start date
2022-10-11
Primary completion
2024-08-21
Enrollment
287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.